NCT07350915 (Active3-WP2) is a NA clinical trial of Digital Therapeutics in Healthy, sponsored by Politecnico di Milano.

Who is sponsoring NCT07350915?

NCT07350915 is sponsored by Politecnico di Milano.

What drugs are being tested in NCT07350915?

Interventions in NCT07350915: Digital Therapeutics.

Is NCT07350915 still recruiting?

NCT07350915 is currently completed. Last updated 20 January 2026.

Last reviewed 2026-01-20 · How we verify

NCT07350915: Active3-WP2

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

ActivE³ - Everyone, Everywhere, Everyday WP 2 - Personalized Data-driven Coaching Platform for Stimulating and Promoting Active Lifestyle and Health Risk Prevention

Completed NA Last updated 20 January 2026

What this trial tests

NA trial testing Digital Therapeutics in Healthy in 237 participants. Completed in 30 September 2025.

Timeline

1 September 2024

Primary endpoint
31 August 2025

30 September 2025

Quick facts

Lead sponsor	Politecnico di Milano
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	237
Start date	1 September 2024
Primary completion	31 August 2025
Estimated completion	30 September 2025
Sites	1 location across Italy

Drugs / interventions tested

Digital Therapeutics

Conditions studied

Healthy — all drugs for Healthy →

Sponsor

Politecnico di Milano

Who can join

Adults 60 to 80, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of WP2 of the Active3 project is to develop a digital solution for promoting and monitoring physical activity in social settings (real or virtual) that implements a Preventive Medicine approach to healthy aging. Specifically, the objective of the action related to Word Package 2 is to develop a personalized, data-driven coaching platform co-designed with local healthcare services, clinicians, technologists, designers, and management engineers to stimulate and promote an active lifestyle and prevent health risks among the over-60 population in Lecco and its province. Active Healthy Aging initiatives, such as the Walking Groups coordinated by local healthcare services, are already active in the Lecco area. This personalized coaching platform aims to leverage these initiatives for prevention and treatment purposes. Its objectives are: * Creating a user-friendly technological tool for local healthcare services/clinical organizations for projects encouraging physical activity as a driver of lifestyle-based prevention; * Test this digital therapeutic practice (with a clinical study) on a cohort of 200 individuals to validate its usability, adherence and preliminary efficacy. The main questions it aims to answer are: Will a Digital Therapeutics (DTx) based on Active Lifestyle and balance nutrition promotion be adopted and used in an elderly propulation? What outcomes in health scores will Active3-WP2 platform achieve in physical, metabolic and cognitive domains? Researchers will compare the use of the proposed DTxA to a contrl gropu receiving a standard educational program. Participants will: * receive the Active3-WP2 platform (App+ Wearable) * participate in health screenings at month 0, month 6 and month 12.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Healthy

Currently open trials in the same condition.

NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting

Other Politecnico di Milano trials

Trials by the same sponsor.

NCT03127241 — User-centred Assistive System for Arm Functions in Neuromuscular Subjects · NA · completed
NCT04497090 — Adaptive Non-invasive Ventilation to Abolish Tidal Flow Limitation · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07350915 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Politecnico di Milano
Last refreshed: 20 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07350915.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing